Hosted on MSN15h
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...
BioPharma Dive10h
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
phillyvoice.com1d
A new blood test accurately screens for colorectal cancer, researchers say
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...
Hosted on MSN1d
Trump Administration Throws Cancer Research Into Turmoil
As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...
abcnews413d
FDA bans Red 3 dye in food, drink and medicine due to cancer risk
Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that ...
Zentalis to Cut 40% of Workforce to Back Development of Cancer-Drug Azenosertib
Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.
AstraZeneca, Daiichi’s drug cleared for wider use in breast cancer patients in US
Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...
Boise State Public Radio1d
The link between artificial food dyes and ADHD in kids
Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...
PBS4d
The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
As Trump and RFK Jr. move to upend drug making, Seattle biotech bets on science
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
JD Supra2d
FDA Revoking Authorization for Use of Red No. 3 in Food and Ingested Drugs
On January 15, 2025, the Food and Drug Administration (FDA) amended its color additive regulations by revoking its ...
Monthly Prescribing Reference1d
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...